Product
CVVH with Biphozyl
1 clinical trial
10 indications
Indication
Critically IllIndication
Acute Kidney InjuryIndication
HemodialysisIndication
Continuous Renal Replacement TherapyIndication
Continuous Veno-Venous HemofiltrationIndication
Replacement FluidIndication
PhoxiliumIndication
BiphozylIndication
Anticoagulant therapyIndication
Regional Citrate AnticoagulationClinical trial
Comparison of Biphozyl® and Phoxilium® as a Replacement Fluid During CVVH for AKI in Adults and Their Effects on pH-, Bicarbonate-levels and Respiratory Situation - A Prospective, Randomized, Controlled, Open, Cross-over, Phase II, Single-center Pilot Study [BiPhox-Trial]Status: Completed, Estimated PCD: 2023-11-15